Literature DB >> 19652869

Neutrophils launch monocyte extravasation by release of granule proteins.

Oliver Soehnlein1, Alma Zernecke, Christian Weber.   

Abstract

During their journey from the blood stream to sites of inflammation polymorphonuclear leukocytes (PMN) release a wide panoply of granule proteins. Shortly after the PMN efflux, the extravasation of monocytes sets in and recent research provides evidence that the release of PMN granule proteins and monocyte extravasation are causally interrelated. Granule proteins seeded on the endothelium by adherent PMN allow direct activation and subsequent adhesion of monocytes. In addition, PMN granule components enhance the endothelial expression of cell adhesion molecules, efficiently supporting the arrest of monocytes at inflamed vessels. Moreover, granule proteins contribute to the fine tuning of the local chemokine network. Proteolytic modification of chemokines as well as enhancement of local chemokine synthesis lead to increased monocyte extravasation. Finally, PMN granule proteins exert direct chemotactic effects, a mechanism which is of special importance in the early recruitment of inflammatory monocytes. Hence, granule proteins modify the monocyte extravasation cascade in a multifaceted manner ensuring the efficiency of these mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652869     DOI: 10.1160/TH08-11-0720

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  30 in total

1.  Stress and skin leukocyte trafficking as a dual-stage process.

Authors:  Elad Neeman; Lee Shaashua; Marganit Benish; Gayle G Page; Oded Zmora; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2011-09-19       Impact factor: 7.217

2.  Biomaterials selectively modulate interactions between human blood-derived polymorphonuclear leukocytes and monocytes.

Authors:  Hannah C Cohen; Evan J Joyce; W John Kao
Journal:  Am J Pathol       Date:  2013-06       Impact factor: 4.307

Review 3.  Direct and alternative antimicrobial mechanisms of neutrophil-derived granule proteins.

Authors:  Oliver Soehnlein
Journal:  J Mol Med (Berl)       Date:  2009-07-31       Impact factor: 4.599

4.  Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury.

Authors:  Sang Mi Lee; Steven Rosen; Philip Weinstein; Nico van Rooijen; Linda J Noble-Haeusslein
Journal:  J Neurotrauma       Date:  2011-08-08       Impact factor: 5.269

5.  Defensin-chemokine heteromeric complexes derived from heterocellular activation-a possible target to inhibit CCL5 in cardiovascular settings.

Authors:  Osamu Baba; Yongjian Liu; Gwendalyn J Randolph
Journal:  Ann Transl Med       Date:  2016-12

6.  Toll-like Receptor 2 Prevents Neutrophil-Driven Immunopathology during Infection with Mycobacterium tuberculosis by Curtailing CXCL5 Production.

Authors:  Archana Gopalakrishnan; Jillian Dietzold; Sheetal Verma; Madhuri Bhagavathula; Padmini Salgame
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

Review 7.  Therapeutic targeting of neutrophil exocytosis.

Authors:  Sergio D Catz; Kenneth R McLeish
Journal:  J Leukoc Biol       Date:  2020-01-28       Impact factor: 4.962

8.  Biomaterials differentially regulate Src kinases and phosphoinositide 3-kinase-γ in polymorphonuclear leukocyte primary and tertiary granule release.

Authors:  Hannah Caitlin Cohen; Dustin C Frost; Tyler Jacob Lieberthal; Lingjun Li; W John Kao
Journal:  Biomaterials       Date:  2015-02-14       Impact factor: 12.479

9.  Yersinia pseudotuberculosis Blocks Neutrophil Degranulation.

Authors:  Nayyer Taheri; Anna Fahlgren; Maria Fällman
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

10.  Neutrophil trails guide influenza-specific CD8⁺ T cells in the airways.

Authors:  Kihong Lim; Young-Min Hyun; Kris Lambert-Emo; Tara Capece; Seyeon Bae; Richard Miller; David J Topham; Minsoo Kim
Journal:  Science       Date:  2015-09-04       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.